Overview

Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare the results during different scanning time points after a contrast drug is given for a FDG PET/CT. The contrast drug helps the researchers "see" the images more clearly.
Phase:
Phase 0
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Fluorodeoxyglucose F18